CTX110 Trademark
CTX110 is a USPTO trademark filed by CRISPR Therapeutics AG. Status: Registered.
Trademark Facts
| Mark | CTX110 |
|---|---|
| Serial Number | 88296694 |
| Registration Number | 6760727 |
| Status | Registered |
| Filing Date | 2019-02-11 |
| Registration Date | 2022-06-14 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | CRISPR Therapeutics AG |
| Attorney of Record | Tiffany D. Gehrke |
| Prosecution Events | 47 |
| Latest Event | R.PR on 2022-06-14 |
Goods & Services
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer | Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development